ArticleBritish journal of cancer2016

Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab.

Charles S Fuchs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.